TY - JOUR
T1 - An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia
AU - Dohmen, Kazufumi
AU - Yamamoto, Asataro
AU - Tanaka, Hirofumi
AU - Haruno, Masatora
AU - Shimoda, Shinji
N1 - Publisher Copyright:
© 2016 The Japan Society of Hepatology.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/3/3
Y1 - 2016/3/3
N2 - A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.
AB - A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.
UR - http://www.scopus.com/inward/record.url?scp=84959456854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959456854&partnerID=8YFLogxK
U2 - 10.2957/kanzo.57.106
DO - 10.2957/kanzo.57.106
M3 - Article
AN - SCOPUS:84959456854
SN - 0451-4203
VL - 57
SP - 106
EP - 112
JO - Acta Hepatologica Japonica
JF - Acta Hepatologica Japonica
IS - 2
ER -